Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gliosarcoma × Dihematoporphyrin Ether × Clear all

Sponsor

Conditions

Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Non-Small-Cell Lung 3 Head and Neck Neoplasms 2 Tongue Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrent Head and Neck Carcinoma 1 Precancerous Conditions 1 Pleural Effusion, Malignant 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Lymphoid Interstitial Pneumonia 1 Leukoplakia, Oral 1 Laryngeal Neoplasms 1 Barrett Esophagus 1

Interventions

Temozolomide 48 Bevacizumab 31 Radiotherapy 24 Radiation 11 Erlotinib Hydrochloride 11 Radiotherapy, Intensity-Modulated 7 Radiotherapy, Conformal 7 Irinotecan 6 Vorinostat 5 Immunoglobulin G 4 Disulfides 4 Carmustine 4 plerixafor 3 carmustine, poliferprosan 20 drug combination 3 Sorafenib 3 Sirolimus 3 Radiosurgery 3 Magnetic Resonance Spectroscopy 3 Everolimus 3 Dasatinib 3 Bortezomib 3 veliparib 2 vandetanib 2 temsirolimus 2 tandutinib 2 sargramostim 2 pazopanib 2 ferric pyrophosphate 2 cediranib 2 Topotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡